Aprea Therapeutics
APRE
#11121
Rank
C$4.66 M
Marketcap
C$0.33
Share price
-53.56%
Change (1 day)
-80.10%
Change (1 year)

Earnings for Aprea Therapeutics (APRE)

Earnings in 2026 (TTM): -C$18.46 Million

According to Aprea Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$18.98 Million, an increase over its 2024 earnings that were of -C$20.54 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aprea Therapeutics from 2019 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$18.46 Million-2.74%
2025 -C$18.98 Million-7.58%
2024 -C$20.54 Million-7.45%
2023 -C$22.19 Million-58.6%
2022 -C$53.6 Million-0.2%
2021 -C$53.7 Million-29.09%
2020 -C$75.74 Million64.34%
2019 -C$46.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Magellan Health
MGLN
C$30.72 M-262.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amedisys
AMED
C$0.21 B-1,229.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Healthcare Services Group
HCSG
C$0.18 B-1,079.35%๐Ÿ‡บ๐Ÿ‡ธ USA